Eileen Schloss - Medidata Solutions Executive Vice President - Human Resources
President
Ms. Eileen M. Schloss is Executive Vice President Human Resources of Medidata Solutions Inc. She has served as our executive vice presidenthuman resources since October 2012. Prior to joining us, Ms. Schloss served as executive vice president at Rovi Corporationrationration, a publicly traded digital media entertainment software and services company, from 2007 to 2012. Prior to that, she held leadership roles in human resources and administration at Caspian Networks, Inc., Exodus Communications, AppGenesys, Inc., Apple Computer, Charles Schwab, Inc. and Tandem Computers, Inc since 2012.
| Age | 61 |
| Tenure | 12 years |
| Phone | 212 918-1800 |
| Web | www.medidata.com |
Eileen Schloss Latest Insider Activity
Tracking and analyzing the buying and selling activities of Eileen Schloss against Medidata Solutions stock is an integral part of due diligence when investing in Medidata Solutions. Eileen Schloss insider activity provides valuable insight into whether Medidata Solutions is net buyers or sellers over its current business cycle. Note, Medidata Solutions insiders must abide by specific rules, including filing SEC forms every time they buy or sell Medidata Solutions'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Eileen Schloss over six months ago Exercise or conversion by Eileen Schloss of 34054 shares of CCC Intelligent subject to Rule 16b-3 |
Medidata Solutions Management Efficiency
The company has return on total asset (ROA) of 7.55 % which means that it generated a profit of $7.55 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 10.86 %, meaning that it created $10.86 on every $100 dollars invested by stockholders. Medidata Solutions' management efficiency ratios could be used to measure how well Medidata Solutions manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 198.87 M in liabilities with Debt to Equity (D/E) ratio of 30.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Medidata Solutions has a current ratio of 2.52, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Medidata Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, Medidata Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medidata Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medidata to invest in growth at high rates of return. When we think about Medidata Solutions' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Jennifer Hale | Stepan Company | 56 | |
| Luis Rojo | Stepan Company | 51 | |
| Debra Stefaniak | Stepan Company | 59 | |
| Bruce Bodine | The Mosaic | 52 | |
| John Manning | Sensient Technologies | 55 | |
| Richard McLellan | The Mosaic | 63 | |
| Mark Kaplan | The Mosaic | 47 | |
| John Collopy | Sensient Technologies | 45 | |
| Scott Behrens | Stepan Company | 54 | |
| Frank Pacholec | Stepan Company | 62 | |
| Kimberly Bors | The Mosaic | 56 | |
| Steve Morris | Sensient Technologies | 60 | |
| Craig Mitchell | Sensient Technologies | 59 | |
| Sean Moriarty | Stepan Company | 51 | |
| Robert Slone | Stepan Company | 45 | |
| Kimberly Morin | Sensient Technologies | 53 | |
| Laura Gagnon | The Mosaic | N/A | |
| Mark Isaacson | The Mosaic | 62 | |
| Tobin Tornehl | Sensient Technologies | 50 | |
| Corrine Ricard | The Mosaic | 61 | |
| Walter Precourt | The Mosaic | 55 | |
Management Performance
| Return On Equity | 10.86 | |||
| Return On Asset | 7.55 |
Medidata Solutions Leadership Team
Elected by the shareholders, the Medidata Solutions' board of directors comprises two types of representatives: Medidata Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medidata. The board's role is to monitor Medidata Solutions' management team and ensure that shareholders' interests are well served. Medidata Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medidata Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Otner, Executive Vice President General Counsel, Corporate Secretary | ||
| Lee Shapiro, Independent Director | ||
| Tarek Sherif, Co-Founder, Chairman and CEO | ||
| Hulus Alpay, Vice President - Investor Relations | ||
| Glen Vries, Co-Founder and President Director and President of Medidata Solutions Worldwide | ||
| Michael Capone, COO | ||
| Anthony DAmico, Senior Director, Investor Relations | ||
| Neil Kurtz, Independent Director | ||
| Carlos Dominguez, Independent Director | ||
| Elena Izmailova, Chief Scientific Officer | ||
| George McCulloch, Independent Director | ||
| Vik Shahwill, COO | ||
| Mary Weger, Executive Vice President—Human Resources | ||
| Michael Pinto, Executive Vice President General Manager - Global Sales | ||
| Rouven Bergmann, CFO and Chief Accounting Officer | ||
| Robert Taylor, Independent Director | ||
| Sastry Chilukuri, Executive Vice President - Digital and AI Solutions | ||
| Eileen Schloss, Executive Vice President - Human Resources | ||
| Michael Pray, Executive Vice President General Manager - Global Sales | ||
| Maria Rivas, Director | ||
| Steven Hirschfeld, Chief Commercial Officer | ||
| Betsy Frank, IR Contact Officer | ||
| Daniel Shannon, Executive Vice President – Global Professional Services | ||
| Gol Ophiris, Head - Business Development |
Medidata Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medidata Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 10.86 | |||
| Return On Asset | 7.55 | |||
| Profit Margin | 9.90 % | |||
| Operating Margin | 11.40 % | |||
| Current Valuation | 5.54 B | |||
| Shares Outstanding | 62.46 M | |||
| Shares Owned By Insiders | 3.80 % | |||
| Shares Owned By Institutions | 96.20 % | |||
| Number Of Shares Shorted | 6.1 M | |||
| Price To Earning | 128.08 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Medidata Stock
If you are still planning to invest in Medidata Solutions check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medidata Solutions' history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |